BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 33152401)

  • 1. LACTB promotes metastasis of nasopharyngeal carcinoma via activation of ERBB3/EGFR-ERK signaling resulting in unfavorable patient survival.
    Peng LX; Wang MD; Xie P; Yang JP; Sun R; Zheng LS; Mei Y; Meng DF; Peng XS; Lang YH; Qiang YY; Li CZ; Xu L; Liu ZJ; Guo LL; Xie DH; Shu DT; Lin ST; Luo FF; Huang BJ; Qian CN
    Cancer Lett; 2021 Feb; 498():165-177. PubMed ID: 33152401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EGFR-PKM2 signaling promotes the metastatic potential of nasopharyngeal carcinoma through induction of FOSL1 and ANTXR2.
    Chen S; Youhong T; Tan Y; He Y; Ban Y; Cai J; Li X; Xiong W; Zeng Z; Li G; Yi M; Liu W; Xiang B
    Carcinogenesis; 2020 Jul; 41(6):723-733. PubMed ID: 31665243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capn4 is induced by and required for Epstein-Barr virus latent membrane protein 1 promotion of nasopharyngeal carcinoma metastasis through ERK/AP-1 signaling.
    Zheng P; Chen X; Xie J; Chen X; Lin S; Ye L; Chen L; Lin J; Yu X; Zheng M
    Cancer Sci; 2020 Jan; 111(1):72-83. PubMed ID: 31691433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S100A14 suppresses metastasis of nasopharyngeal carcinoma by inhibition of NF-kB signaling through degradation of IRAK1.
    Meng DF; Sun R; Liu GY; Peng LX; Zheng LS; Xie P; Lin ST; Mei Y; Qiang YY; Li CZ; Xu L; Peng XS; Hu H; Lang YH; Liu ZJ; Wang MD; Guo LL; Xie DH; Shu DT; Li HF; Luo FF; Niu XT; Huang BJ; Qian CN
    Oncogene; 2020 Jul; 39(30):5307-5322. PubMed ID: 32555330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNTTIP1 promotes nasopharyngeal carcinoma metastasis via recruiting HDAC1 to DUSP2 promoter and activating ERK signaling pathway.
    Ding S; Gao Y; Lv D; Tao Y; Liu S; Chen C; Huang Z; Zheng S; Hu Y; Chow LK; Wei Y; Feng P; Dai W; Wang X; Xia Y
    EBioMedicine; 2022 Jul; 81():104100. PubMed ID: 35689852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CDC42-interacting protein 4 promotes metastasis of nasopharyngeal carcinoma by mediating invadopodia formation and activating EGFR signaling.
    Meng DF; Xie P; Peng LX; Sun R; Luo DH; Chen QY; Lv X; Wang L; Chen MY; Mai HQ; Guo L; Guo X; Zheng LS; Cao L; Yang JP; Wang MY; Mei Y; Qiang YY; Zhang ZM; Yun JP; Huang BJ; Qian CN
    J Exp Clin Cancer Res; 2017 Jan; 36(1):21. PubMed ID: 28129778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXA1 reprograms the TGF-β-stimulated transcriptional program from a metastasis promoter to a tumor suppressor in nasopharyngeal carcinoma.
    Li J; Wang W; Chen S; Cai J; Ban Y; Peng Q; Zhou Y; Zeng Z; Li X; Xiong W; Li G; Yi M; Xiang B
    Cancer Lett; 2019 Feb; 442():1-14. PubMed ID: 30392786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opa interacting protein 5 promotes metastasis of nasopharyngeal carcinoma cells by promoting EMT via modulation of JAK2/STAT3 signal.
    Zheng YQ; Cui YR; Yang S; Wang YP; Qiu YJ; Hu WL
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):613-621. PubMed ID: 30720169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reducing NETO2 expression prevents human nasopharyngeal carcinoma (NPC) progression by suppressing metastasis and inducing apoptosis.
    He AR; Zhu Q; Gao S
    Biochem Biophys Res Commun; 2019 May; 513(2):494-501. PubMed ID: 30975469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus-coded miR-BART13 promotes nasopharyngeal carcinoma cell growth and metastasis via targeting of the NKIRAS2/NF-κB pathway.
    Xu YJ; Zhou R; Zong JF; Lin WS; Tong S; Guo QJ; Lin C; Lin SJ; Chen YX; Chen MR; Chen HL; Ye YB; Pan JJ
    Cancer Lett; 2019 Apr; 447():33-40. PubMed ID: 30684592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BarH-like homeobox 2 represses the transcription of keratin 16 and affects Ras signaling pathway to suppress nasopharyngeal carcinoma progression.
    Lu Z; Peng H; Li R; Xu X; Peng J
    Bioengineered; 2022 Feb; 13(2):3122-3136. PubMed ID: 35037835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastasis-suppressing NID2, an epigenetically-silenced gene, in the pathogenesis of nasopharyngeal carcinoma and esophageal squamous cell carcinoma.
    Chai AW; Cheung AK; Dai W; Ko JM; Ip JC; Chan KW; Kwong DL; Ng WT; Lee AW; Ngan RK; Yau CC; Tung SY; Lee VH; Lam AK; Pillai S; Law S; Lung ML
    Oncotarget; 2016 Nov; 7(48):78859-78871. PubMed ID: 27793011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High COX-2 expression in cancer-associated fibiroblasts contributes to poor survival and promotes migration and invasiveness in nasopharyngeal carcinoma.
    Zhu Y; Shi C; Zeng L; Liu G; Jiang W; Zhang X; Chen S; Guo J; Jian X; Ouyang J; Xia J; Kuang C; Fan S; Wu X; Wu Y; Zhou W; Guan Y
    Mol Carcinog; 2020 Mar; 59(3):265-280. PubMed ID: 31867776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WNT5A promotes stemness characteristics in nasopharyngeal carcinoma cells leading to metastasis and tumorigenesis.
    Qin L; Yin YT; Zheng FJ; Peng LX; Yang CF; Bao YN; Liang YY; Li XJ; Xiang YQ; Sun R; Li AH; Zou RH; Pei XQ; Huang BJ; Kang TB; Liao DF; Zeng YX; Williams BO; Qian CN
    Oncotarget; 2015 Apr; 6(12):10239-52. PubMed ID: 25823923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mTORC2-mediated PDHE1α nuclear translocation links EBV-LMP1 reprogrammed glucose metabolism to cancer metastasis in nasopharyngeal carcinoma.
    Zhang J; Jia L; Liu T; Yip YL; Tang WC; Lin W; Deng W; Lo KW; You C; Lung ML; Lung HL; Cheung AL; Tsao SW; Tsang CM
    Oncogene; 2019 Jun; 38(24):4669-4684. PubMed ID: 30745576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of novel signaling components in N,N'-dinitrosopiperazine-mediated metastasis of nasopharyngeal carcinoma by quantitative phosphoproteomics.
    Huang D; Li Y; Liu N; Zhang Z; Peng Z; Duan C; Tang X; Tan G; Yan G; Tang F
    BMC Cancer; 2014 Apr; 14():243. PubMed ID: 24708550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA LOC284454 promotes migration and invasion of nasopharyngeal carcinoma via modulating the Rho/Rac signaling pathway.
    Fan C; Tang Y; Wang J; Wang Y; Xiong F; Zhang S; Li X; Xiang B; Wu X; Guo C; Ma J; Zhou M; Li X; Xiong W; Li Y; Li G; Zeng Z
    Carcinogenesis; 2019 Apr; 40(2):380-391. PubMed ID: 30380023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Notch1 inactivation promotes invasion and metastasis of nasopharyngeal carcinoma cells partly through Slug activation.
    An JS; Rho YS; Moon JH; Lim YC
    Neoplasma; 2020 Mar; 67(2):259-266. PubMed ID: 31777263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UBE2T promotes nasopharyngeal carcinoma cell proliferation, invasion, and metastasis by activating the AKT/GSK3β/β-catenin pathway.
    Hu W; Xiao L; Cao C; Hua S; Wu D
    Oncotarget; 2016 Mar; 7(12):15161-72. PubMed ID: 26943030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of RKIP expression promotes nasopharyngeal carcinoma invasion and metastasis by activating Stat3 signaling.
    He QY; Yi HM; Yi H; Xiao T; Qu JQ; Yuan L; Zhu JF; Li JY; Wang YY; Li LN; Feng J; Lu SS; Xiao ZQ
    Oncotarget; 2015 Jun; 6(18):16422-36. PubMed ID: 25915430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.